LMR Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-63,813
Closed -$7.22M 1701
2025
Q1
$7.22M Buy
+63,813
New +$6.83M 0.07% 315
2023
Q4
Sell
-8,709
Closed -$977K 1152
2023
Q3
$977K Buy
+8,709
New +$1.11M 0.01% 489
2022
Q2
Sell
-2,718
Closed -$348K 1493
2022
Q1
$348K Buy
+2,718
New +$328K ﹤0.01% 1047
2020
Q3
Sell
-13,489
Closed -$1.56M 655
2020
Q2
$1.56M Buy
+13,489
New +$1.55M 0.04% 295
2020
Q1
Sell
-3,616
Closed -$526 461
2019
Q4
$526 Buy
+3,616
New +$499K ﹤0.01% 294
2017
Q3
Sell
-9,607
Closed -$1.2M 573
2017
Q2
$1.2M Buy
+9,607
New +$1.14M 0.08% 272
2016
Q1
Sell
-2,200
Closed -$219K 434
2015
Q4
$219K Buy
+2,200
New +$215K 0.07% 197
2015
Q2
Sell
-5,447
Closed -$621K 615
2015
Q1
$621K Buy
5,447
+1,626
+43% +$186K 0.09% 255
2014
Q4
$420K Buy
+3,821
New +$403K 0.05% 306
2014
Q3
Sell
-13,742
Closed -$1.39M 493
2014
Q2
$1.39M Buy
+13,742
New +$1.34M 0.12% 215

Other funds holding ZBH

LMR Partners's ZBH Position: Q2 2025 in Review

LMR Partners sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 63,813 shares — an estimated $7.22M sold.

LMR Partners first reported a position in ZBH in Q2 2014 and held it in 10 quarters. The position peaked at $7.22M in Q1 2025. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • LMR Partners reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 63,813 Zimmer Biomet shares in Q2 2025, an estimated $7.22M.
  • LMR Partners first reported a position in Zimmer Biomet in Q2 2014 and held it in 10 quarters.
  • LMR Partners's Zimmer Biomet position peaked at $7.22M in Q1 2025.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.